Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging

Area of Science:

• Pediatric Anesthesiology
• Medical Imaging
• Pharmacology

Background:

• Propofol is a common sedative for pediatric MRI, but higher doses risk deep sedation and respiratory issues.
• Optimizing propofol dosage is crucial to balance sedation effectiveness with minimizing adverse respiratory events in children.
• Investigating a low-dose propofol regimen aims to improve safety and efficacy in pediatric MRI sedation.

Purpose of the Study:

• To evaluate the safety and efficacy of a low-dose propofol-based sedation regimen for pediatric MRI.
• To determine the optimal dosage of propofol for achieving adequate sedation while minimizing respiratory depression in a broad age range of children.
• To assess key outcomes including induction time, sedation duration, recovery time, and adverse events.

Main Methods:

• Prospective investigation of 500 infants and children undergoing MRI.
• Administered premedication with midazolam (0.1 mg/kg IV) followed by nalbuphine (0.1 mg/kg IV) and propofol (1 mg/kg IV) for induction.
• Maintained sedation with propofol (5 mg/kg/h IV), monitoring induction/sedation/recovery times, need for additional sedation, and respiratory/cardiovascular events.

Main Results:

• Data collected from 53 infants and 447 children (median age 5.3 years).
• Achieved rapid induction (2 min), sedation (55 min), and recovery (8 min) times.
• Low incidence of adverse events: 2.2% required additional sedation, 1% experienced mild respiratory events; no paradoxical reactions or sedation failures.

Conclusions:

• The investigated low-dose propofol regimen demonstrates the shortest induction time reported to date.
• This sedation protocol resulted in a low incidence of adverse respiratory events and minimal need for additional sedation.
• The regimen ensures successful MRI completion with rapid recovery, highlighting its safety and efficacy in pediatric patients.